Search research articles
Contact Us
Filters
Showing results (41-50 of 54) with videos related to
Page
of 6
Sort By:
Bioorganic Chemistry
|
April 5, 2026
Optimization of novel quinazolinone derivatives as CRBN E3 ligase modulators for enhanced degradative activity and metabolic stability
Peng Chen, Hongkang Peng, Chen Liu, et al.
Journal of Periodontal Research
|
February 9, 2022
Wnt4 regulates bone metabolism through IKK-NF-κB and ROCK signaling under occlusal traumatic periodontitis
Weizhe Xu, Qian Lu, Moyuan Qu, et al.
Frontiers in Pharmacology
|
November 19, 2024
Novel <i>N</i>-phenyl-2-(aniline) benzamide hydrochloride salt development for colon cancer therapy
Yan Peng, Ying Peng, Wei Zhang, et al.
Cancer Biology & Medicine
|
February 17, 2026
SARS-CoV-2 infection in brain tumors and the association with alterations in the tumor immune microenvironment
Weikang Chen, Haojie Bai, Maoling Tian, et al.
Frontiers in Endocrinology
|
April 27, 2026
Intact mTOR signaling in gastric X/A-like cells is required for bone homeostasis
Tiange Feng, Wenzhen Yin, Caroline C Picoli, et al.
European Journal of Medicinal Chemistry
|
March 29, 2023
Corrigendum to "Discovery of novel BCR-ABL PROTACs based on the cereblon E3 ligase design, synthesis, and biological evaluation" [Eur. J. Med. Chem. 223 (2021) 11-05 113645]
Haixia Liu, Xinyu Ding, Linyi Liu, et al.
European Journal of Medicinal Chemistry
|
July 3, 2021
Discovery of novel BCR-ABL PROTACs based on the cereblon E3 ligase design, synthesis, and biological evaluation
Haixia Liu, Xinyu Ding, Linyi Liu, et al.
European Journal of Medicinal Chemistry
|
September 7, 2024
Identification of a novel 10-hydroxyevodiamine prodrug as a potent topoisomerase inhibitor with improved aqueous solubility for treatment of hepatocellular carcinoma
Xiuzhen Wei, Xi Zhang, Yan Peng, et al.
Journal of Medicinal Chemistry
|
September 21, 2019
Discovery of SIAIS178 as an Effective BCR-ABL Degrader by Recruiting Von Hippel-Lindau (VHL) E3 Ubiquitin Ligase
Quanju Zhao, Chaowei Ren, Linyi Liu, et al.
European Journal of Medicinal Chemistry
|
October 28, 2022
Discovery and characterization of novel potent BCR-ABL degraders by conjugating allosteric inhibitor
Haixia Liu, Qianglong Mi, Xinyu Ding, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 54) with videos related to
Sort By:
Page
of 6
Bioorganic Chemistry
|
April 5, 2026
Optimization of novel quinazolinone derivatives as CRBN E3 ligase modulators for enhanced degradative activity and metabolic stability
Peng Chen, Hongkang Peng, Chen Liu, et al.
Journal of Periodontal Research
|
February 9, 2022
Wnt4 regulates bone metabolism through IKK-NF-κB and ROCK signaling under occlusal traumatic periodontitis
Weizhe Xu, Qian Lu, Moyuan Qu, et al.
Frontiers in Pharmacology
|
November 19, 2024
Novel <i>N</i>-phenyl-2-(aniline) benzamide hydrochloride salt development for colon cancer therapy
Yan Peng, Ying Peng, Wei Zhang, et al.
Cancer Biology & Medicine
|
February 17, 2026
SARS-CoV-2 infection in brain tumors and the association with alterations in the tumor immune microenvironment
Weikang Chen, Haojie Bai, Maoling Tian, et al.
Frontiers in Endocrinology
|
April 27, 2026
Intact mTOR signaling in gastric X/A-like cells is required for bone homeostasis
Tiange Feng, Wenzhen Yin, Caroline C Picoli, et al.
European Journal of Medicinal Chemistry
|
March 29, 2023
Corrigendum to "Discovery of novel BCR-ABL PROTACs based on the cereblon E3 ligase design, synthesis, and biological evaluation" [Eur. J. Med. Chem. 223 (2021) 11-05 113645]
Haixia Liu, Xinyu Ding, Linyi Liu, et al.
European Journal of Medicinal Chemistry
|
July 3, 2021
Discovery of novel BCR-ABL PROTACs based on the cereblon E3 ligase design, synthesis, and biological evaluation
Haixia Liu, Xinyu Ding, Linyi Liu, et al.
European Journal of Medicinal Chemistry
|
September 7, 2024
Identification of a novel 10-hydroxyevodiamine prodrug as a potent topoisomerase inhibitor with improved aqueous solubility for treatment of hepatocellular carcinoma
Xiuzhen Wei, Xi Zhang, Yan Peng, et al.
Journal of Medicinal Chemistry
|
September 21, 2019
Discovery of SIAIS178 as an Effective BCR-ABL Degrader by Recruiting Von Hippel-Lindau (VHL) E3 Ubiquitin Ligase
Quanju Zhao, Chaowei Ren, Linyi Liu, et al.
European Journal of Medicinal Chemistry
|
October 28, 2022
Discovery and characterization of novel potent BCR-ABL degraders by conjugating allosteric inhibitor
Haixia Liu, Qianglong Mi, Xinyu Ding, et al.
Page
of 6